Home/Filings/4/0001415889-25-007783
4//SEC Filing

Luo Mary Z. 4

Accession 0001415889-25-007783

CIK 0001297184other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 4:03 PM ET

Size

13.4 KB

Accession

0001415889-25-007783

Insider Transaction Report

Form 4
Period: 2025-03-10
Zhang Jack Y.
DirectorCEO & CHIEF SCIENTIFIC OFFICER10% Owner
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-10+246,821246,821 total
    Exercise: $28.41Exp: 2035-03-10Common Stock (246,821 underlying)
  • Award

    Common Stock

    2025-03-10+48,9961,148,257 total(indirect: See footnote)
  • Award

    Employee Stock Option (right to buy)

    2025-03-10+104,052104,052 total(indirect: See footnote)
    Exercise: $28.41Exp: 2035-03-10Common Stock (104,052 underlying)
  • Award

    Common Stock

    2025-03-10+116,2262,609,382 total
Holdings
  • Common Stock

    (indirect: See footnote)
    6,827,679
Luo Mary Z.
DirectorCOO, Chief Scientist, Chairman10% Owner
Transactions
  • Award

    Common Stock

    2025-03-10+116,2262,609,382 total
  • Award

    Common Stock

    2025-03-10+48,9961,148,257 total(indirect: See footnote)
  • Award

    Employee Stock Option (right to buy)

    2025-03-10+104,052104,052 total(indirect: See footnote)
    Exercise: $28.41Exp: 2035-03-10Common Stock (104,052 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-03-10+246,821246,821 total
    Exercise: $28.41Exp: 2035-03-10Common Stock (246,821 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    6,827,679
Footnotes (4)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on March 10, 2026.
  • [F2]The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
  • [F3]The shares are held of record by Applied Physics and Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
  • [F4]The shares subject to the option vest in four equal annual installments beginning on March 10, 2026.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001611156

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:03 PM ET
Size
13.4 KB